Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

Por Sekulic, Aleksandar, Migden, Michael R., Basset-Seguin, Nicole, Garbe, Claus, Gesierich, Anja, Lao, Christopher D., Miller, Chris, Mortier, Laurent, Murrell, Dedee F., Hamid, Omid, Quevedo, Jorge F., Hou, Jeannie, McKenna, Edward, Dimier, Natalie, Williams, Sarah, Schadendorf, Dirk, Hauschild, Axel
Publicado no BMC Cancer (2017)

Androgen receptor variant AR-V9 is co-expressed with AR-V7 in prostate cancer metastases and predicts abiraterone resistance

Por Kohli, Manish, Ho, Yeung, Hillman, David W., Van Etten, Jamie L., Henzler, Christine, Yang, Rendong, Sperger, Jamie M., Li, Yingming, Tseng, Elizabeth, Hon, Ting, Clark, Tyson, Tan, Winston, Carlson, Rachel E., Wang, Liguo, Sicotte, Hugues, Thai, Ho, Jimenez, Rafael, Huang, Haojie, Vedell, Peter T., Eckloff, Bruce W., Quevedo, Jorge F., Pitot, Henry C., Costello, Brian A., Jen, Jin, Wieben, Eric D., Silverstein, Kevin A.T., Lang, Joshua M., Wang, Liewei, Dehm, Scott M.
Publicado no Clin Cancer Res (2017)